*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Squibb/NNP Corp./NNP ]
bought/VBD marketing/NN 
[ rights/NNS ]
to/TO 
[ a/DT family/NN ]
of/IN 
[ experimental/JJ drugs/NNS ]
that/IN ,/, 
[ its/PRP$ developer/NN claims/NNS ]
,/, hold/VBP 
[ promise/NN ]
for/IN 
[ treating/VBG acne/NN ]
,/, 
[ skin/NN ]
wrinkling/VBG and/CC 
[ baldness/NN ]
./. 

======================================

[ Squibb/NNP ]
is/VBZ buying/VBG 
[ the/DT rights/NNS ]
,/, for/IN 
[ an/DT amount/NN ]

[ that/DT was/VBD n't/RB ]
disclosed/VBN ,/, from/IN 
[ Chantal/NNP Pharmaceutical/NNP Corp./NNP ]
,/, 
[ a/DT small/JJ Los/NNP Angeles/NNP company/NN ]

[ that/WDT ]
discovered/VBD and/CC has/VBZ been/VBN testing/VBG 
[ the/DT drugs/NNS ]
./. 

[ Chantal/NNP ]
said/VBD 
[ it/PRP ]
is/VBZ in/IN 
[ advanced/JJ stages/NNS ]
of/IN testing/VBG 
[ one/CD ]
of/IN 
[ the/DT drugs/NNS ]
,/, 
[ Cyoctol/NNP ]
,/, as/IN 
[ a/DT topical/JJ treatment/NN ]
for/IN 
[ mild/JJ ]
to/TO 
[ severe/JJ acne/NN ]
./. 

[ Another/DT ]
chemically/RB related/VBN 
[ drug/NN ]
,/, called/VBN 
[ Ethocyn/NNP ]
,/, is/VBZ being/VBG tested/VBN as/IN 
[ an/DT anti-wrinkling/JJ cream/NN ]
./. 

======================================

[ The/DT acquisition/NN ]
is/VBZ expected/VBN to/TO generate/VB 
[ wide/JJ interest/NN ]
because/IN 
[ there/EX ]
has/VBZ been/VBN 
[ much/JJ publicity/NN ]
in/IN 
[ recent/JJ years/NNS ]
over/IN 
[ drugs/NNS ]

[ which/WDT ]
are/VBP being/VBG touted/VBN as/RB hair-growing/JJ or/CC 
[ wrinkle-fighting/JJ treatments/NNS ]
./. 

[ Sales/NNS ]
of/IN 
[ Johnson/NNP ]
&/CC 
[ Johnson/NNP 's/POS Retin-A/NNP acne/NN drug/NN ]
have/VBP increased/VBN sharply/RB since/IN 
[ reports/NNS ]
were/VBD released/VBN that/IN 
[ it/PRP ]
can/MD smooth/VB 
[ some/DT wrinkles/NNS ]
./. 

======================================

[ Upjohn/NNP Co./NNP last/JJ year/NN ]
received/VBD 
[ the/DT first/JJ government/NN approval/NN ]
to/TO sell/VB 
[ a/DT drug/NN ]
,/, 
[ Rogaine/NNP ]
,/, for/IN 
[ hair/NN loss/NN ]
./. 

======================================

[ The/DT Chantal/NNP drugs/NNS ]
are/VBP different/JJ from/IN 
[ these/DT compounds/NNS ]
in/IN that/IN 
[ they/PRP ]
are/VBP 
[ so-called/JJ anti-androgens/NNS ]
./. 

[ The/DT drugs/NNS ]
apparently/RB block/VB 
[ the/DT action/NN ]
of/IN 
[ male/JJ hormones/NNS ]
that/IN ,/, when/WRB released/VBN by/IN 
[ the/DT body/NN ]
in/IN 
[ excessive/JJ amounts/NNS ]
,/, are/VBP believed/VBN to/TO cause/VB 
[ such/JJ problems/NNS ]
as/IN 
[ acne/NN ]
and/CC 
[ baldness/NN ]
./. 

[ Many/JJ drug/NN companies/NNS ]
have/VBP searched/VBN in/IN 
[ vain/JJ ]
for/IN 
[ years/NNS ]
for/IN 
[ safe/JJ anti-androgen/JJ drugs/NNS ]
./. 

[ The/DT first/JJ compound/NN ]

[ which/WDT ]
led/VBD to/TO 
[ the/DT development/NN ]
of/IN 
[ the/DT Chantal/NNP drugs/NNS ]
was/VBD discovered/VBN by/IN 
[ the/DT company/NN 's/POS chairman/NN ]
and/CC 
[ chief/JJ executive/NN officer/NN ]
,/, 
[ Chantal/NNP Burnison/NNP ]
,/, in/IN 
[ 1978/CD ]
./. 

[ The/DT company/NN ]
,/, formed/VBN in/IN 
[ 1979/CD ]
,/, began/VBD 
[ clinical/JJ trials/NNS ]
of/IN 
[ the/DT drugs/NNS ]
about/RB 
[ four/CD years/NNS ]
ago/RB ,/, but/CC has/VBZ yet/RB to/TO release/VB 
[ any/DT results/NNS ]
publicly/RB ./. 

======================================

``/`` 
[ We/PRP ]
have/VBP 
[ data/NNS ]

[ that/WDT ]
indicate/VBP that/IN 
[ the/DT drugs/NNS ]
are/VBP working/VBG ,/, that/IN 
[ they/PRP ]
are/VBP very/RB safe/JJ and/CC 
[ effective/NN ]
,/, ''/'' 
[ Ms./NNP Burnison/NNP ]
said/VBD in/IN 
[ a/DT telephone/NN interview/NN ]
./. 

``/`` 
[ We/PRP ]
showed/VBD 
[ the/DT studies/NNS ]
to/TO 
[ Squibb/NNP ]
and/CC 
[ that/DT ]
's/VBZ why/WRB 
[ they/PRP ]
agreed/VBD to/TO sign/VB 
[ a/DT deal/NN ]
./. 

''/'' 
======================================

[ Ms./NNP Burnison/NNP ]
said/VBD 
[ the/DT company/NN ]
did/VBD n't/RB want/VB to/TO release/VB 
[ the/DT studies/NNS ]
,/, performed/VBN by/IN 
[ outside/JJ researchers/NNS ]
,/, until/IN 
[ it/PRP ]
had/VBD received/VBN 
[ patent/JJ protection/NN ]
and/CC had/VBD found/VBN 
[ a/DT marketing/NN partner/NN ]
./. 

[ She/PRP ]
said/VBD 
[ a/DT study/NN ]
of/IN 
[ the/DT drug/NN 's/POS use/NN ]
in/IN 
[ treating/VBG baldness/NN ]
would/MD be/VB released/VBN at/IN 
[ a/DT medical/JJ meeting/NN ]
in/IN 
[ December/NNP ]
./. 

In/IN 
[ over-the-counter/JJ ]
trading/NN ,/, 
[ Chantal/NNP shares/NNS ]
were/VBD trading/VBG at/IN 
[ $/$ 3.1875/CD ]
,/, down/RB 
[ 18.75/CD cents/NNS ]
./. 

======================================

In/IN 
[ Princeton/NNP ]
,/, 
[ N.J./NNP ]
,/, 
[ a/DT spokeswoman/NN ]
for/IN 
[ Squibb/NNP ]
declined/VBD to/TO release/VB 
[ details/NNS ]
of/IN 
[ the/DT drugs/NNS '/POS studies/NNS ]
,/, but/CC said/VBD that/IN ``/`` 
[ there/EX ]
was/VBD 
[ sufficient/JJ data/NN ]
to/TO support/VB 
[ our/PRP$ interest/NN ]
in/IN 
[ this/DT opportunity/NN ]
./. 

''/'' 
[ Ms./NNP Burnison/NNP ]
said/VBD 
[ Squibb/NNP ]
was/VBD especially/RB interested/VBN in/IN 
[ the/DT acne/NN treatment/NN ]
./. 

======================================

[ She/PRP ]
said/VBD 
[ the/DT drug/NN ]
would/MD compete/VB against/IN 
[ Accutane/NNP ]
,/, 
[ the/DT anti-acne/NN drug/NN ]
sold/VBN by/IN 
[ Hoffmann-La/NNP Roche/NNP Inc./NNP ]
,/, 
[ the/DT U.S./NNP unit/NN ]
of/IN 
[ the/DT Swiss/NNP company/NN ]
,/, 
[ F./NNP Hoffmann-LaRoche/NNP ]
&/CC 
[ Co/NNP ]
./. 

[ Accutane/NNP ]
,/, while/IN very/RB 
[ effective/NN ]
,/, is/VBZ restricted/VBN to/TO 
[ very/RB severe/JJ acne/NN cases/NNS ]
because/IN 
[ it/PRP ]
can/MD cause/VB 
[ birth/NN defects/NNS ]
when/WRB taken/VBN by/IN 
[ pregnant/JJ women/NNS ]
./. 

======================================

[ Ms./NNP Burnison/NNP ]
said/VBD 
[ Chantal/NNP ]
wanted/VBD to/TO sign/VB on/RP with/IN 
[ Squibb/NNP ]
because/IN of/IN 
[ that/DT company/NN 's/POS pending/VBG merger/NN ]
with/IN 
[ Bristol-Myers/NNP Co./NNP ]
,/, 
[ New/NNP York/NNP ]
./. 

[ Chantal/NNP ]
believes/VBZ 
[ the/DT drugs/NNS ]
,/, 
[ which/WDT ]
are/VBP being/VBG developed/VBN for/IN 
[ the/DT prescription/NN market/NN ]
,/, may/MD be/VB safe/JJ enough/RB to/TO sell/VB eventually/RB as/IN 
[ non-prescription/JJ products/NNS ]
./. 

[ Bristol-Myers/NNP ]
has/VBZ 
[ a/DT large/JJ non-prescription/NN business/NN ]
./. 

======================================

[ Chantal/NNP ]
said/VBD 
[ the/DT agreement/NN ]
``/`` brings/VBZ 
[ solid/JJ financial/JJ resources/NNS ]
to/TO 
[ the/DT company/NN ]
./. 
